JP Stock MarketDetailed Quotes

3349 COSMOS Pharmaceutical

Watchlist
  • 11655.0
  • -1160.0-9.05%
20min DelayNot Open Jul 16 15:00 JST
466.21BMarket Cap18.88P/E (Static)

COSMOS Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

COSMOS Pharmaceutical Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

Jul 12, 2024

Revenue(YoY)

249.68B

+12.77%
EPS(YoY)

179.08

-5.62%
Analyst Rating

Buy

Jul 12, 2024

COSMOS Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 255.815B--
--2025/Q1-- / 264.405B--
Jul 12, 20242024/Q4249.678B / 251.307B--
Apr 12, 20242024/Q3238.881B / 234.831B--
Jan 12, 20242024/Q2234.777B / 230.672B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 255.815B--
--2025/Q1-- / 264.405B--
Jul 12, 20242024/Q4249.678B / 251.307B--
Apr 12, 20242024/Q3238.881B / 234.831B--
Jan 12, 20242024/Q2234.777B / 230.672B--

Unlock Free Earnings Estimates

COSMOS Pharmaceutical Earnings Reports

  • COSMOS Pharmaceutical: Financial results summary for the May 2024 term based on Japanese standards (consolidated).

    Jul 12 02:00 ET

  • Cosmos Pharmaceuticals: Confirmation Form

    Apr 15 04:00 ET

  • Cosmos Pharmaceuticals: Quarterly Report - 42nd Term 3rd Quarter (2023/12/01 - 2024/02/29)

    Apr 15 03:59 ET

  • COSMOS Pharmaceutical: Summary of Financial Results for the 3rd Quarter Ending May 2024 [Japanese GAAP] (Consolidated)

    Apr 12 02:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 12, 2024

    Buy

    • Strong Buy

      33.33%

    • Buy

      16.67%

    • Hold

      33.33%

    • Underperform

      8.33%

    • Sell

      8.33%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg